Lipin proteins and metabolic homeostasis

Journal of Lipid Research

Volumn 50, Issue SUPPL., 2009, Pages

  Reue, Karen ^a   Dwyer, Jennifer R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Insulin resistance; Lipodystrophy; Obesity; Phosphatidate phosphatase; Triglyceride

Indexed keywords

INSULIN; LIPOPROTEIN; NUCLEAR PROTEIN;

ADIPOGENESIS; ANIMAL; CLASSIFICATION; ENZYME SPECIFICITY; GENETICS; HOMEOSTASIS; HUMAN; METABOLISM; REVIEW; SECRETION;

ADIPOGENESIS; ANIMALS; HOMEOSTASIS; HUMANS; INSULIN; LIPOPROTEINS; NUCLEAR PROTEINS; SUBSTRATE SPECIFICITY;

EID: 84863494132     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R800052-JLR200     Document Type: Review

References (41)

1. Péterfy, M., J. Phan, P. Xu, and K. Reue. 2001. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat. Genet. 27: 121-124. (Pubitemid 32044532)
2. Langner, C. A., E. H. Birkenmeier, O. Ben-Zeev, M. C. Schotz, H. O. Sweet, M. T. Davisson, and J. I. Gordon. 1989. The fatty liver dystrophy (f ld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue-specific defects in lipoprotein lipase and hepatic lipase activities. J. Biol. Chem. 264: 7994-8003. (Pubitemid 19137280)
3. Langner, C. A., E. H. Birkenmeier, K. A. Roth, R. T. Bronson, and J. I. Gordon. 1991. Characterization of the peripheral neuropathy in neonatal and adult mice that are homozygous for the fatty liver dystrophy (fld) mutation. J. Biol. Chem. 266: 11955-11964. (Pubitemid 21907042)
4. Reue, K., P. Xu, X. P. Wang, and B. G. Slavin. 2000. Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene. J. Lipid Res. 41: 1067-1076. (Pubitemid 30483010)
5. Huffman, T. A., I. Mothe-Satney, and J. C. Lawrence, Jr. 2002. Insulin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin. Proc. Natl. Acad. Sci. USA. 99:1047-1052. (Pubitemid 34106633)
6. Péterfy, M., J. Phan, and K. Reue. 2005. Alternatively spliced lipin isoforms exhibit distinct expression pattern, subcellular localization, and role in adipogenesis. J. Biol. Chem. 280: 32883-32889. (Pubitemid 41368337)
7. Carman, G. M., and G. S. Han. 2009. Phosphatidic acid phosphatase, a key enzyme in the regulation of lipid synthesis. J. Biol. Chem. 284:2593-2597.
8. Reue, K., and D. N. Brindley. 2008. Multiple roles for lipins/ phosphatidate phosphatase enzymes in lipid metabolism. J. Lipid Res. 49: 2493-2503
9. Han, G. S., W. I. Wu, and G. M. Carman. 2006. The Saccharomyces cerevisiae Lipin homolog is a Mg21-dependent phosphatidate phosphatase enzyme. J. Biol. Chem. 281: 9210-9218.
10. Donkor, J., M. Sariahmetoglu, J. Dewald, D. N. Brindley, and K. Reue. 2007. Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. J. Biol. Chem. 282:3450-3457. (Pubitemid 47084457)
11. Harris, T. E., T. A. Huffman, A. Chi, J. Shabanowitz, D. F. Hunt, A. Kumar, and J. C. Lawrence, Jr. 2007. Insulin controls subcellular localization and multisite phosphorylation of the phosphatidic acid phosphatase, lipin 1. J. Biol. Chem. 282: 277-286. (Pubitemid 47076630)
12. Bou Khalil, M., M. Sundaram, H. Y. Zhang, P. H. Links, J. F. Raven, B. Manmontri, M. Sariahmetoglu, K. Tran, K. Reue, D. N. Brindley, et al. 2009. The level and compartmentalization of phosphatidate phosphatase-1 (lipin-1) control the assembly and secretion of hepatic VLDL. J. Lipid Res. 50: 47-58.
13. Finck, B. N., M. C. Gropler, Z. Chen, T. C. Leone, M. A. Croce, T. E. Harris, J. C. Lawrence, Jr., and D. P. Kelly. 2006. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab. 4: 199-210. (Pubitemid 44283957)
14. Phan, J., M. Péterfy, and K. Reue. 2004. Lipin expression preceding peroxisome proliferator-activated receptor-gamma is critical for adipogenesis in vivo and in vitro. J. Biol. Chem. 279: 29558-29564. (Pubitemid 38915837)
15. Grimsey, N., G. S. Han, L. O'Hara, J. J. Rochford, G. M. Carman, and S. Siniossoglou. 2008. Temporal and spatial regulation of the phosphatidate phosphatases lipin 1 and 2. J. Biol. Chem. 283:29166-29174.
16. Phan, J., and K. Reue. 2005. Lipin, a lipodystrophy and obesity gene. Cell Metab. 1: 73-83. (Pubitemid 43960586)
17. Suviolahti, E., K. Reue, R. M. Cantor, J. Phan, M. Gentile, J. Naukkarinen, A. Soro-Paavonen, L. Oksanen, J. Kaprio, A. Rissanen, et al. 2006. Cross-species analyses implicate Lipin 1 involvement in human glucose metabolism. Hum. Mol. Genet. 15: 377-386. (Pubitemid 43159890)
18. Yao-Borengasser, A., N. Rasouli, V. Varma, L. M. Miles, B. Phanavanh, T. N. Starks, J. Phan, H. J. Spencer III, R. E. McGehee, Jr., K. Reue, et al. 2006. Lipin expression is attenuated in adipose tissue of insulin-resistant human subjects and increases with peroxisome proliferator-activated receptor gamma activation. Diabetes. 55:2811-2818. (Pubitemid 44923681)
19. Donkor, J., L. M. Sparks, H. Xie, S. R. Smith, and K. Reue. 2008. Adipose tissue lipin-1 expression is correlated with peroxisome proliferator-activated receptor alpha gene expression and insulin sensitivity in healthy young men. J. Clin. Endocrinol. Metab. 93:233-239.
20. Unger, R. H. 2002. Lipotoxic diseases. Annu. Rev. Med. 53: 319-336. (Pubitemid 34177884)
21. van Harmelen, V., M. Ryden, E. Sjolin, and J. Hoffstedt. 2007. A role of lipin in human obesity and insulin resistance: relation to adipocyte glucose transport and GLUT4 expression. J. Lipid Res. 48: 201-206. (Pubitemid 46052912)
22. Waki, H., K. W. Park, N. Mitro, L. Pei, R. Damoiseaux, D. C. Wilpitz, K. Reue, E. Saez, and P. Tontonoz. 2007. The small molecule harmine is an anti-diabetic cell-type specific regulator of PPARg expression. Cell Metab. 5: 357-370. (Pubitemid 46667757)
23. Kim, Y., M. S. Gentry, T. E. Harris, S. E. Wiley, J. C. Lawrence, Jr., and J. E. Dixon. 2007. A conserved phosphatase cascade that regulates nuclear membrane biogenesis. Proc. Natl. Acad. Sci. USA. 104: 6596-6601. (Pubitemid 47175546)
24. Santos-Rosa, H., J. Leung, N. Grimsey, S. Peak-Chew, and S. Siniossoglou. 2005. The yeast lipin Smp2 couples phospholipid biosynthesis to nuclear membrane growth. EMBO J. 24: 1931-1941. (Pubitemid 40896165)
25. Verheijen, M. H., R. Chrast, P. Burrola, and G. Lemke. 2003. Local regulation of fat metabolism in peripheral nerves. Genes Dev. 17:2450-2464. (Pubitemid 37214792)
26. Nadra, K., A. S. de Preux Charles, J. J. Medard, W. T. Hendriks, G. S. Han, S. Gres, G. M. Carman, J. S. Saulnier-Blache, M. H. Verheijen, and R. Chrast. 2008. Phosphatidic acid mediates demyelination in Lpin1 mutant mice. Genes Dev. 22: 1647-1661. (Pubitemid 351846844)
27. Manmontri, B., M. Sariahmetoglu, J. Donkor, M. B. Khalil, M. Sundaram, Z. Yao, K. Reue, R. Lehner, and D. N. Brindley. 2008. Glucocorticoids and cyclic AMP selectively increase hepatic lipin-1 expression, and insulin acts antagonistically. J. Lipid Res. 49: 1056-1067.
28. Zhang, P., L. O'Loughlin, D. N. Brindley, and K. Reue. 2008. Regulation of lipin-1 gene expression by glucocorticoids during adipogenesis. J. Lipid Res. 49: 1519-1528.
29. Chen, Z., M. C. Gropler, J. Norris, J. C. Lawrence, Jr., T. E. Harris, and B. N. Finck. 2008. Alterations in hepatic metabolism in fld mice reveal a role for lipin 1 in regulating VLDL-triacylglyceride secretion. Arterioscler. Thromb. Vasc. Biol. 28: 1738-1744.
30. Croce, M. A., J. C. Eagon, L. L. LaRiviere, K. M. Korenblat, S. Klein, and B. N. Finck. 2007. Hepatic lipin 1beta expression is diminished in insulin-resistant obese subjects and is reactivated by marked weight loss. Diabetes. 56: 2395-2399. (Pubitemid 47358247)
31. Cao, H., and R. A. Hegele. 2002. Identification of single-nucleotide polymorphisms in the human LPIN1 gene. J. Hum. Genet. 47:370-372. (Pubitemid 34733516)
32. Fawcett, K. A., N. Grimsey, R. J. Loos, E. Wheeler, A. Daly, M. Soos, R. Semple, H. Syddall, C. Cooper, S. Siniossoglou, et al. 2008. Evaluating the role of LPIN1 variation on insulin resistance, body weight and human lipodystrophy in UK populations. Diabetes. 57: 2527-2533.
33. Zeharia, A., A. Shaag, R. H. Houtkooper, T. Hindi, P. de Lonlay, G. Erez, L. Hubert, A. Saada, Y. de Keyzer, G. Eshel, et al. 2008. Mutations in LPIN1 cause recurrent acute myoglobinuria in childhood. Am. J. Hum. Genet. 83: 489-494.
34. Loos, R. J., T. Rankinen, L. Perusse, A. Tremblay, J. P. Despres, and C. Bouchard. 2007. Association of lipin 1 gene polymorphisms with measures of energy and glucose metabolism. Obesity (Silver Spring). 15: 2723-2732.
35. Wiedmann, S., M. Fischer, M. Koehler, K. Neureuther, G. Riegger, A. Doering, H. Schunkert, C. Hengstenberg, and A. Baessler. 2008. Genetic variants within the LPIN1 gene, encoding lipin, are influencing phenotypes of the metabolic syndrome in humans. Diabetes. 57: 209-217.
36. Kang, E. S., S. E. Park, S. J. Han, S. H. Kim, C. M. Nam, C. W. Ahn, B. S. Cha, K. S. Kim, and H. C. Lee. 2008. LPIN1 genetic variation is associated with rosiglitazone response in type 2 diabetic patients. Mol Genet Metab. 95: 96-100.
37. Ong, K. L., R. Y. Leung, L. Y. Wong, S. S. Cherny, P. C. Sham, T. H. Lam, K. S. Lam, and B. M. Cheung. 2008. Association of a polymorphism in the lipin 1 gene with systolic blood pressure in men. Am. J. Hypertens. 21: 539-545. (Pubitemid 351589675)
38. Sirvent, P., J. Mercier, and A. Lacampagne. 2008. New insights into mechanisms of statin-associated myotoxicity. Curr. Opin. Pharmacol. 8: 333-338.
39. Al-Mosawi, Z. S., K. K. Al-Saad, R. Ijadi-Maghsoodi, H. I. El-Shanti, and P. J. Ferguson. 2007. A splice site mutation confirms the role of LPIN2 in Majeed syndrome. Arthritis Rheum. 56: 960-964. (Pubitemid 46399443)
40. Ferguson, P. J., S. Chen, M. K. Tayeh, L. Ochoa, S. M. Leal, A. Pelet, A. Munnich, S. Lyonnet, H. A. Majeed, and H. El-Shanti. 2005. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J. Med. Genet. 42:551-557. (Pubitemid 40993830)
41. Aulchenko, Y. S., J. Pullen, W. P. Kloosterman, M. Yazdanpanah, A. Hofman, N. Vaessen, P. J. Snijders, D. Zubakov, I. Mackay, M. Olavesen, et al. 2007. LPIN2 is associated with type 2 diabetes, glucose metabolism, and body composition. Diabetes. 56: 3020-3026. (Pubitemid 350223638)